Olympus (7733) Status update summary

Market trends and growth opportunities

• Global endoscopy procedures are growing at 5% annually, driven by aging populations and increased cancer prevalence.

• Expanding access in underserved markets could quadruple annual procedures to 600 million, but barriers like clinician training and infrastructure persist.

• Expansion opportunities exist by scaling minimally invasive procedures and increasing access in underserved regions.

Strategic vision and future care ecosystem

• Envisions broader access, faster diagnosis, and minimally invasive treatments, improving patient outcomes and clinician workflows.

• Administrators will benefit from increased reliability, efficiency, and resource optimization, supported by a global installed base and partnerships.

• Focus on advanced, less invasive endoscopy for better patient outcomes and faster recovery.

Technology and innovation priorities

• Integrates imaging, therapeutic devices, digital solutions, AI, and robotics into a seamless ecosystem for diagnosis, treatment, and equipment management.

• OLYSENSE, an AI-supported endoscopy platform, aims to connect up to 25% of the install base by FY 2031, with 5% integration by FY28.

• Endoluminal robotics and advanced diagnostic solutions are prioritized, targeting a $2 billion US market by 2040.

• Near-term launches in GI, urology, and respiratory segments to drive incremental growth.